keew
2021-04-27
Please comment. Thanks
Top U.S. trade negotiator meets Pfizer, AstraZeneca execs on COVID-19 IP waiver
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
3
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":377913225,"tweetId":"377913225","gmtCreate":1619488688167,"gmtModify":1634212345725,"author":{"id":3575231727264140,"idStr":"3575231727264140","authorId":3575231727264140,"authorIdStr":"3575231727264140","name":"keew","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":5,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Please comment. Thanks</p></body></html>","htmlText":"<html><head></head><body><p>Please comment. Thanks</p></body></html>","text":"Please comment. Thanks","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/377913225","repostId":2130334923,"repostType":4,"repost":{"id":"2130334923","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1619488599,"share":"https://www.laohu8.com/m/news/2130334923?lang=&edition=full","pubTime":"2021-04-27 09:56","market":"us","language":"en","title":"Top U.S. trade negotiator meets Pfizer, AstraZeneca execs on COVID-19 IP waiver","url":"https://stock-news.laohu8.com/highlight/detail?id=2130334923","media":"Reuters","summary":"WASHINGTON, April 26 (Reuters) - U.S. Trade Representative Katherine Tai on Monday met virtually wit","content":"<p>WASHINGTON, April 26 (Reuters) - U.S. Trade Representative Katherine Tai on Monday met virtually with top executives of drugmakers Pfizer and AstraZeneca <a href=\"https://laohu8.com/S/PLC\">PLC</a> to discuss a proposed waiver of certain intellectual property rights in response to the COVID-19 pandemic.</p>\n<p>Members of the World Trade Organization are due to discuss a proposal by India and South Africa to waive certain provisions of the WTO's Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) on April 30, but the United States and a few other big countries have blocked such a move.</p>\n<p>Democratic lawmakers, civil society groups, and 60 former heads of state and 100 Nobel Prize winners have urged President Joe Biden to back the waiver. White House Press Secretary Jen Psaki on Monday said she had no updates on the issue.</p>\n<p>Tai's meetings with the Pfizer and AstraZeneca executives reflect her intense engagement on the issue, and follow similar meetings with advocacy groups, industry executives and others.</p>\n<p>Earlier this month, Tai told a WTO meeting the gaping divide between developed and developing countries' access to medicines was \"completely unacceptable\" and industry needed to make sacrifices in times of crisis.</p>\n<p>In her discussion with Pfizer Chief Executive Dr. Albert Bourla, Tai emphasized her commitment to working with other members of the WTO on a global response to the crisis, her office said in a statement.</p>\n<p>That included \"the role of developing countries in any solution that addresses critical gaps in global production and distribution of vaccines,\" USTR said.</p>\n<p>Tai also discussed the issue with Dr. Ruud Dobber, head of U.S. business at AstraZeneca, as well as the White House's decision to share up to 60 million doses of AstraZeneca's COVID-19 vaccine with countries in need.</p>\n<p>USTR said Tai and Dobber discussed \"increasing vaccine production, global health issues and the proposed waiver.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top U.S. trade negotiator meets Pfizer, AstraZeneca execs on COVID-19 IP waiver</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop U.S. trade negotiator meets Pfizer, AstraZeneca execs on COVID-19 IP waiver\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-04-27 09:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>WASHINGTON, April 26 (Reuters) - U.S. Trade Representative Katherine Tai on Monday met virtually with top executives of drugmakers Pfizer and AstraZeneca <a href=\"https://laohu8.com/S/PLC\">PLC</a> to discuss a proposed waiver of certain intellectual property rights in response to the COVID-19 pandemic.</p>\n<p>Members of the World Trade Organization are due to discuss a proposal by India and South Africa to waive certain provisions of the WTO's Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) on April 30, but the United States and a few other big countries have blocked such a move.</p>\n<p>Democratic lawmakers, civil society groups, and 60 former heads of state and 100 Nobel Prize winners have urged President Joe Biden to back the waiver. White House Press Secretary Jen Psaki on Monday said she had no updates on the issue.</p>\n<p>Tai's meetings with the Pfizer and AstraZeneca executives reflect her intense engagement on the issue, and follow similar meetings with advocacy groups, industry executives and others.</p>\n<p>Earlier this month, Tai told a WTO meeting the gaping divide between developed and developing countries' access to medicines was \"completely unacceptable\" and industry needed to make sacrifices in times of crisis.</p>\n<p>In her discussion with Pfizer Chief Executive Dr. Albert Bourla, Tai emphasized her commitment to working with other members of the WTO on a global response to the crisis, her office said in a statement.</p>\n<p>That included \"the role of developing countries in any solution that addresses critical gaps in global production and distribution of vaccines,\" USTR said.</p>\n<p>Tai also discussed the issue with Dr. Ruud Dobber, head of U.S. business at AstraZeneca, as well as the White House's decision to share up to 60 million doses of AstraZeneca's COVID-19 vaccine with countries in need.</p>\n<p>USTR said Tai and Dobber discussed \"increasing vaccine production, global health issues and the proposed waiver.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AZN":"阿斯利康","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2130334923","content_text":"WASHINGTON, April 26 (Reuters) - U.S. Trade Representative Katherine Tai on Monday met virtually with top executives of drugmakers Pfizer and AstraZeneca PLC to discuss a proposed waiver of certain intellectual property rights in response to the COVID-19 pandemic.\nMembers of the World Trade Organization are due to discuss a proposal by India and South Africa to waive certain provisions of the WTO's Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) on April 30, but the United States and a few other big countries have blocked such a move.\nDemocratic lawmakers, civil society groups, and 60 former heads of state and 100 Nobel Prize winners have urged President Joe Biden to back the waiver. White House Press Secretary Jen Psaki on Monday said she had no updates on the issue.\nTai's meetings with the Pfizer and AstraZeneca executives reflect her intense engagement on the issue, and follow similar meetings with advocacy groups, industry executives and others.\nEarlier this month, Tai told a WTO meeting the gaping divide between developed and developing countries' access to medicines was \"completely unacceptable\" and industry needed to make sacrifices in times of crisis.\nIn her discussion with Pfizer Chief Executive Dr. Albert Bourla, Tai emphasized her commitment to working with other members of the WTO on a global response to the crisis, her office said in a statement.\nThat included \"the role of developing countries in any solution that addresses critical gaps in global production and distribution of vaccines,\" USTR said.\nTai also discussed the issue with Dr. Ruud Dobber, head of U.S. business at AstraZeneca, as well as the White House's decision to share up to 60 million doses of AstraZeneca's COVID-19 vaccine with countries in need.\nUSTR said Tai and Dobber discussed \"increasing vaccine production, global health issues and the proposed waiver.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":93,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":20,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/377913225"}
精彩评论